Eagle Bay Advisors’s Novo Nordisk NVO Stock Holding History

Eagle Bay Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-859	Closed	-$43.7K	–	219
2025 Q4	$43.7K	Buy	+859	New	+$43.9K	0.03%	153
2025 Q1	–	Sell	-182	Closed	-$15.7K	–	688
2024 Q4	$15.7K	Buy	182 +36	+25%	+$3.89K	0.01%	502
2024 Q3	$17.4K	Buy	146 +18	+14%	+$2.4K	0.01%	658
2024 Q2	$18.3K	Buy	128 +30	+31%	+$3.98K	0.01%	452
2024 Q1	$12.7K	Sell	98 -14	-13%	-$1.67K	0.01%	523
2023 Q4	$11.6K	Buy	112 +12	+12%	+$1.19K	0.01%	500
2023 Q3	$9.09K	Buy	100 +22	+28%	+$1.94K	﹤0.01%	607
2023 Q2	$6.31K	Buy	+78	New	+$6.37K	﹤0.01%	641
2022 Q1	–	Sell	-50	Closed	-$3K	–	736
2021 Q4	$3K	Sell	50 -94	-65%	-$5.09K	﹤0.01%	871
2021 Q3	$6K	Buy	+144	New	+$6.96K	﹤0.01%	806

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Eagle Bay Advisors's NVO Position: Q1 2026 in Review

Eagle Bay Advisors sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 859 shares — an estimated $43.7K sold.

Eagle Bay Advisors first reported a position in NVO in Q3 2021 and held it in 10 quarters. The position peaked at $43.7K in Q4 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Eagle Bay Advisors reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Eagle Bay Advisors sold 859 Novo Nordisk shares in Q1 2026, an estimated $43.7K.
Eagle Bay Advisors first reported a position in Novo Nordisk in Q3 2021 and held it in 10 quarters.
Eagle Bay Advisors's Novo Nordisk position peaked at $43.7K in Q4 2025.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.